Agmatine attenuates methamphetamine-induced conditioned place preference in rats

European Journal of Pharmacology

Volumn 680, Issue 1-3, 2012, Pages 69-72

  Thorn, David A ^a   Winter, Jerrold C ^a   Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Agmatine; Conditioned place preference; Methamphetamine; Rat; Rewarding

Indexed keywords

AGMATINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; LOCOMOTION; MOTOR ACTIVITY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

AGMATINE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 84862777105     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.01.037     Document Type: Article

References (36)

1. M.T. Bardo, and R.A. Bevins Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153 2000 31 43 (Berl) (Pubitemid 32127902)
2. A. DeMarco, R.M. Dalal, J. Pai, S.D. Aquilina, U. Mullapudi, C. Hammel, S.K. Kothari, M. Kahanda, C.N. Liebling, V. Patel, W.K. Schiffer, J.D. Brodie, and S.L. Dewey Racemic gamma vinyl-GABA (R, S-GVG) blocks methamphetamine- triggered reinstatement of conditioned place preference Synapse 63 2009 87 94
3. Y. Feng, A.E. Halaris, and J.E. Piletz Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection J. Chromatogr. B: Biomed. Sci. Appl. 691 1997 277 286 (Pubitemid 27214603)
4. A.E. Fleckenstein, T.J. Volz, and G.R. Hanson Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications Neuropharmacology 56 Suppl. 1 2009 133 138
5. D. French, and J.M. Witkin Effects of the dopamine release inhibitor, CGS 10746B, on the locomotor stimulant and discriminative stimulus effects of cocaine and methamphetamine Pharmacol. Biochem. Behav. 46 1993 989 993
6. A. Halaris, and J. Plietz Agmatine: metabolic pathway and spectrum of activity in brain CNS Drugs 21 2007 885 900 (Pubitemid 47557104)
7. H.C. Karadag, A. Ulugol, M. Tamer, Y. Ipci, and I. Dokmeci Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats Neurosci. Lett. 339 2003 88 90 (Pubitemid 36263227)
8. O. Keynan, Y. Mirovsky, S. Dekel, V.H. Gilad, and G.M. Gilad Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial Pain Med. 11 2010 356 368
9. K.F. Kitto, and C.A. Fairbanks Supraspinally administered agmatine prevents the development of supraspinal morphine analgesic tolerance Eur. J. Pharmacol. 536 2006 133 137
10. A. Kyle, and B. Hansell The Meth Epidemic in America: Two Surveys of US counties 2005 Natl. Assoc. Cties Washington, DC
11. J.X. Li, and Y. Zhang Imidazoline I2 receptors: target for new analgesics? Eur. J. Pharmacol. 658 2011 49 56
12. J. Li, X. Li, G. Pei, and B.Y. Qin Effects of agmatine on tolerance to and substance dependence on morphine in mice Zhongguo Yao Li Xue Bao 20 1999 232 238 (Pubitemid 29135321)
13. J.X. Li, Y. Zhang, and J.C. Winter Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I(2) receptor ligands Eur. J. Pharmacol. 669 2011 59 65
14. N. Nicosia, R. Pacula, B. Kilmer, R. Lundberg, and J. Chiesa The Economic Cost of Methamphetamine Use in the United States Drug Policy Res. Cent. 2005 RAND Corp Santa Monica, CA
15. NSDUH Results from the 2007 National Survey on Drug Use and Health: National Findings 2007 http://oas.samhsa.gov/nsduh/2k7nsduh/2k7results.pdf
16. W. Raasch, S. Regunathan, G. Li, and D.J. Reis Agmatine, the bacterial amine, is widely distributed in mammalian tissues Life Sci. 56 1995 2319 2330
17. S.M. Rawls, R.J. Tallarida, and J. Zisk Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy Eur. J. Pharmacol. 553 2006 89 98 (Pubitemid 44779583)
18. S.M. Rawls, K. Gerber, Z. Ding, C. Roth, and R.B. Raffa Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians Synapse 62 2008 927 934
19. S.C. Roerig Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception Ann. N. Y. Acad. Sci. 1009 2003 116 126 (Pubitemid 38265095)
20. C. Sampson, Y. Zhang, F. Del Bello, and J.X. Li Effects of imidazoline I2 receptor ligands on acute nociception in rats NeuroReport 23 2012 73 77
21. R.J. Smith, and G. Aston-Jones Alpha(2) adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking Biol. Psychiatry 70 2011 712 719
22. R.B. Su, Y.H. Ren, Y. Liu, T. Ding, X.Q. Lu, N. Wu, Z.M. Liu, and J. Li Agmatine inhibits morphine-induced drug discrimination in rats Eur. J. Pharmacol. 593 2008 62 67
23. R.B. Su, W.P. Wang, X.Q. Lu, N. Wu, Z.M. Liu, and J. Li Agmatine blocks acquisition and re-acquisition of intravenous morphine self-administration in rats Pharmacol. Biochem. Behav. 92 2009 676 682
24. P. Tahsili-Fahadan, N. Yahyavi-Firouz-Abadi, M.A. Khoshnoodi, R. Motiei-Langroudi, S.A. Tahaei, M.H. Ghahremani, and A.R. Dehpour Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha2-adrenoceptors Neuropsychopharmacology 31 2006 1722 1732 (Pubitemid 44106703)
25. D.A. Thorn, Y. Zhang, B.W. Peng, J.C. Winter, and J.X. Li Effects of imidazoline I(2) receptor ligands on morphine- and tramadol-induced antinociception in rats Eur. J. Pharmacol. 670 2-3 2011 435 440
26. T.M. Tzschentke Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues Prog. Neurobiol. 56 1998 613 672 (Pubitemid 29012461)
27. T.M. Tzschentke Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12 2007 227 462 (Pubitemid 47196347)
28. UNODC United Nations Office on Drugs and Crime. World Drug Report, 2010. Austria Vienna 2010
29. T.I. Uzbay The pharmacological importance of agmatine in the brain Neurosci. Biobehav. Rev. 36 2012 502 519
30. F.J. Vocci, and N.M. Appel Approaches to the development of medications for the treatment of methamphetamine dependence Addiction 102 Suppl. 1 2007 96 106 (Pubitemid 46328210)
31. R.M. Voigt, A.A. Herrold, and T.C. Napier Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats Behav. Neurosci. 125 2011 261 267
32. R.M. Voigt, A.L. Mickiewicz, and T.C. Napier Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats Behav. Brain Res. 225 2011 91 96
33. X.L. Wei, R.B. Su, X.Q. Lu, Y. Liu, S.Z. Yu, B.L. Yuan, and J. Li Inhibition by agmatine on morphine-induced conditioned place preference in rats Eur. J. Pharmacol. 515 2005 99 106 (Pubitemid 40779274)
34. X.L. Wei, R.B. Su, N. Wu, X.Q. Lu, J.Q. Zheng, and J. Li Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats Eur. Neuropsychopharmacol. 17 2007 790 799 (Pubitemid 47588863)
35. N. Wu, R.B. Su, and J. Li Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence Cell. Mol. Neurobiol. 28 2008 629 641 (Pubitemid 351905063)
36. E. Zakharova, G. Leoni, I. Kichko, and S. Izenwasser Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats Behav. Brain Res. 198 2009 45 50